分析联用丹红注射液与依达拉奉注射液治疗脑梗死患者的临床有效性

Analysis of the Combined Use of Danhong Injection and Edaravone Injection in the Treatment of Patients With Cerebral Infarction

目的分析联用丹红注射液与依达拉奉注射液治疗脑梗死患者的临床有效性。方法研究对象为经我院确诊的60例脑梗死患者（2015年6月-2016年6月）。按照随机方法划分为：对照组30例,年龄为46-79岁;研究组30例,年龄为49-81岁,对两组患者的最终治疗效果进行分析。结果研究组的治疗总体有效率以及神经功能缺损评分均优于对照组（P〈0.05）。结论对脑梗死患者采用丹红注射液联合依达拉奉注射液的治疗方法,效果显著。

Objective To analyze the effectiveness of Danhong injection combined with Edaravone Injection in treatment of patients with cerebral infarction. Methods 60 cases of cerebral infarction（from June 2015 to June 2016）were diagnosed by our hospital. According to the random method,were divided into control group of 30 cases,the age range was 46 to 79 years old,and study group of 30 cases,age range was 49 to 81 years old. The final treatment effect of the two groups of patients were analyzed. Results The total effective rate and neurological deficit scores in the study group were better than those in the control group（P〈0.05）. Conclusion The patients with cerebral infarction treated by Danhong injection combined with Edaravone Injection,the effect is significant.